Article

Video keeps patients currenton interstital cystitis

The Interstitial Cystitis Association's new video, IC: The Basics, offers up-to-date information on theories, treatments, self-help measures, and research developments in interstitial cystitis.

The Interstitial Cystitis Association's new video, IC: The Basics, offers up-to-date information on theories, treatments, self-help measures, and research developments in interstitial cystitis. Presented by Robert Moldwin, MD, author of The Interstitial Cystitis Survival Guide, it is available in DVD or VHS formats, with special pricing for ICA members.

For information, visit www.ichelp.org.

Related Videos
John P. Mulhall, MD, answers a question during a Zoom video interview
Hailey Frye answers a question during a Zoom video interview
Dr Louise Kostos answers a question during a Zoom video interview
Medcast series
1 expert in this video
Neeraja Tillu, MD, answers a question during a Zoom video interview
Related Content
Real-world data reaffirm oncologic benefits of BLC for NMIBC
March 19th 2025

Real-world data reaffirm oncologic benefits of BLC for NMIBC

Hannah Clarke
"These data support current AUA/SUO guidelines recommending BLC usage in patients with NMIBC to increase detection and decrease recurrence," says Stephen B. Williams, MD, MBA, MS, FACS, FACHE.
Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management
March 3rd 2025

Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management

Max Kates, MD Neal Shore, MD, FACS Katie S. Murray, DO, MS
Panelists discuss the impact of long-term care in patients with non–muscle-invasive bladder cancer (NMIBC), considering the unique needs of specific patient groups and highlighting advancements in NMIBC treatment that may support better care experiences for patients.
FDA greenlights trial of orellanine in metastatic renal cell carcinoma
March 18th 2025

FDA greenlights trial of orellanine in metastatic renal cell carcinoma

Hannah Clarke
The study will evaluate the investigational drug product ONC175 (orellanine) in patients with metastatic clear cell or papillary renal cell carcinoma.
Episode 4 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management
February 21st 2025

Episode 4 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management

Max Kates, MD Neal Shore, MD, FACS Katie S. Murray, DO, MS
Panelists discuss the impact of long-term care in patients with non–muscle-invasive bladder cancer (NMIBC), considering the unique needs of specific patient groups and highlighting advancements in NMIBC treatment that may support better care experiences for patients.
Exercise may improve erectile function in men with prostate cancer
March 17th 2025

Exercise may improve erectile function in men with prostate cancer

Hannah Clarke
“The study suggests that exercise would be an effective intervention for men with prostate cancer who express concern about sexual dysfunction, and that exercise medicine should be considered a key part of their treatment,” says Daniel Galvão, PhD.
Michael R. Folkert, MD, PhD, answers a question during a Zoom video interview
March 17th 2025

Michael R. Folkert, MD, PhD, discusses real-world outcomes with spacer in prostate cancer

Michael R. Folkert, MD, PhD Benjamin P. Saylor
"4 years following radiation therapy, there is a 25% lower hazard of bowel disorders and a 46% lower hazard of related procedures [in patients who received a spacer],” says Michael R. Folkert, MD, PhD.
© 2025 MJH Life Sciences

All rights reserved.